Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aryeh Babkoff

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|August 3, 2021
Aurora-B phosphorylates the myosin II heavy chain to promote cytokinesisAryeh Babkoff, Einav Cohen-Kfir, Hananel Aharon, et al.
Journal of Cell Science|July 19, 2019
A direct interaction between survivin and myosin II is required for cytokinesisAryeh Babkoff, Einav Cohen-Kfir, Hananel Aharon, et al.
Case Reports in Oncology|October 30, 2023
First Female Patient with a Rare CIC-FOXO4-Translocated Sarcoma: A Case ReportAryeh Babkoff, Yael Berner-Wygoda, Judith Diment, et al.
Oncology Research|April 3, 2026
BRAF <sup><b>V600E</b></sup> Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature ReviewDaniel Burg, Aryeh Babkoff, Omer Or, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|August 3, 2021
Aurora-B phosphorylates the myosin II heavy chain to promote cytokinesisAryeh Babkoff, Einav Cohen-Kfir, Hananel Aharon, et al.
Journal of Cell Science|July 19, 2019
A direct interaction between survivin and myosin II is required for cytokinesisAryeh Babkoff, Einav Cohen-Kfir, Hananel Aharon, et al.
Case Reports in Oncology|October 30, 2023
First Female Patient with a Rare CIC-FOXO4-Translocated Sarcoma: A Case ReportAryeh Babkoff, Yael Berner-Wygoda, Judith Diment, et al.
Oncology Research|April 3, 2026
BRAF <sup><b>V600E</b></sup> Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature ReviewDaniel Burg, Aryeh Babkoff, Omer Or, et al.
Pageof 1